Clinical Trials List
2026-06-01 - 2032-11-30
Phase II/III
Not yet recruiting5
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- YAO CHI-YUAN 無
- Chien-Chin Lin 無
- 李思慧 無
- Wen-Chien Chou 無
- Huai-Hsuan Huang 無
- 楊鎰聰 無
- - - 無
- Chieh-Lung Cheng 無
- 林明恩 無
- Shang-Ju Wu 無
- CHENG-HONG TSAI 無
- MING YAO 無
- 李婉瑄 無
- 田豐銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chi-Ching Chen 無
- Tzu-Ting Chen 無
- 鄭富銘 無
- Ching-Chan Lin 無
- 王幸婷 無
- Ming-Yu Lien 無
- 陳珈妤 無
- Che-Hung Lin 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 滕傑林 無
- PO-HSIEN LI 無
- 鄧齡喬 無
- CHENG-HSIEN LIN 無
- PO-WEI LIAO 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
660 participants
